FGF9 and adenoma: For FGF9 (Figure 1F), the combination of anastrozole and fulvestrant showed a significant reduction of high scores in preneoplasias (P < 0.0002) and in adenomas (P < 0.0002), while single treatments were not significantly different from placebo.